Tune in today catch our very own project management experts, Paul B Cook, PhD, PMP, Joyce Pinkham and Mariamawit Gebremeskel as they discuss the diversity of project management approaches and share their experiences as PMs in a dynamic biotech environment with PIPMG.
Looking forward to working with my colleagues, Joyce Pinkham and Mari Gebremeskel, to share the diversity of PM applications in our small-ish biotech company.
Congratulations to Generation Bio Sr. Scientist Anthony Dawson for his presentation at the Cell & Gene Therapy International / BioProcess International Conference last week! Anthony discussed our Rapid Enzymatic Synthesis (RES) process, which is designed to significantly improve the speed, quality, and scalability of DNA manufacturing compared to traditional cell-based methods. If you missed it, you can check out the slides from Anthony's presentation on our website: https://lnkd.in/eDnPmsRK #BioProcessInternational #BPI2024 #CGT2024
We are pleased to announce the latest progress in our mission to unlock the full potential of genetic medicine through the latest advancements with our cell-targeted LNP (ctLNP) platform. Learn more in our press release here: https://lnkd.in/eiwzBrAz
Today, Generation Bio announced an exciting step forward in our mission to realize the full potential of non-viral DNA therapeutics with the development of a proprietary, novel DNA called immune-quiet DNA (iqDNA). Read our press release here to learn more: https://lnkd.in/eN8axuDw
Last week, our Chief Scientific Officer, Matthew Stanton, discussed the key hurdles for non-viral DNA delivery and innate immune stimulation, as well as strategies to address these challenges in an online webinar with the Oligonucleotide Therapeutics Society. Check it out here to learn more: https://bit.ly/45yQjxs
